RxSight, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
RxSight, Inc. (RXST) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-05
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$262.00K, a 125.36% decline year-over-year.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.25M.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $1.70M, a 51.26% decline year-over-year.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.56M, a 58.19% decline year-over-year.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$1.88M, a 131.95% decline from fiscal 2024.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $5.87M, a 153.63% increase from fiscal 2023.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.31M, a 51.92% decline from fiscal 2022.
- RxSight, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $4.81M, a 30.68% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.52M 10-Q · filed 2026-08-05 | $181.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.25M 10-Q · filed 2026-05-06 | $443.00K derived: sum of 2 quarters · filed 2026-05-06 | $2.00M derived: sum of 3 quarters · filed 2026-05-06 | $3.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.25M derived: sum of 2 quarters · filed 2026-02-25 | $4.29M derived: sum of 3 quarters · filed 2026-08-05 | -$1.88M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.59M derived: sum of 2 quarters · filed 2026-08-05 | -$3.57M 10-Q · filed 2025-11-05 | -$89.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.13M 10-Q · filed 2026-08-05 | -$1.65M derived: sum of 3 quarters · filed 2026-08-05 | $2.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$6.16M 10-Q · filed 2026-05-06 | -$2.68M derived: sum of 2 quarters · filed 2026-05-06 | $1.04M derived: sum of 3 quarters · filed 2026-05-06 | $3.44M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.21M derived: sum of 2 quarters · filed 2026-02-25 | $9.61M derived: sum of 3 quarters · filed 2026-02-25 | $5.87M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.12M derived: sum of 2 quarters · filed 2025-11-05 | $2.38M 10-Q · filed 2025-11-05 | $4.58M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.34M 10-Q · filed 2025-08-07 | $856.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$3.74M 10-Q · filed 2025-05-07 | -$1.54M derived: sum of 2 quarters · filed 2026-02-25 | $586.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.07M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.32M derived: sum of 2 quarters · filed 2026-02-25 | $5.80M derived: sum of 3 quarters · filed 2026-02-25 | $2.31M 10-K · filed 2026-02-25 |
| 2023-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.61M derived: sum of 2 quarters · filed 2024-11-07 | $119.00K 10-Q · filed 2024-11-07 | $2.54M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$2.01M 10-Q · filed 2024-08-05 | $417.00K derived: sum of 3 quarters · filed 2025-02-25 | $2.79M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$3.49M 10-Q · filed 2024-05-06 | -$1.06M derived: sum of 2 quarters · filed 2025-02-25 | $1.31M derived: sum of 3 quarters · filed 2025-02-25 | $2.77M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $4.80M derived: sum of 2 quarters · filed 2025-02-25 | $6.26M derived: sum of 3 quarters · filed 2025-02-25 | $4.81M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.84M derived: sum of 2 quarters · filed 2023-11-09 | $2.39M 10-Q · filed 2023-11-09 | $3.99M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $17.00K 10-Q · filed 2023-08-07 | $1.62M derived: sum of 3 quarters · filed 2023-08-07 | $2.85M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$1.45M 10-Q · filed 2023-05-09 | $152.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.39M derived: sum of 3 quarters · filed 2023-05-09 | $2.73M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $2.84M derived: sum of 2 quarters · filed 2023-03-06 | $4.18M derived: sum of 3 quarters · filed 2023-03-06 | $3.68M 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.58M derived: sum of 2 quarters · filed 2022-11-07 | $2.08M 10-Q · filed 2022-11-07 | $1.58M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $846.00K 10-Q · filed 2022-08-08 | $347.00K derived: sum of 3 quarters · filed 2022-08-08 | $833.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$498.00K 10-Q · filed 2022-05-05 | -$997.00K derived: sum of 2 quarters · filed 2022-05-05 | -$511.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$13.00K derived: sum of 2 quarters · filed 2022-03-08 | -$3.69M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.19M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$3.68M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |